These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 15371341)

  • 41. Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex.
    Masuda Y; Saeki Y; Arai N; Kawai H; Kukimoto I; Tanaka K; Masutani C
    J Biol Chem; 2019 Oct; 294(41):14860-14875. PubMed ID: 31492752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53.
    Zanier K; ould M'hamed ould Sidi A; Boulade-Ladame C; Rybin V; Chappelle A; Atkinson A; Kieffer B; Travé G
    Structure; 2012 Apr; 20(4):604-17. PubMed ID: 22483108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.
    Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bmi-1 cooperates with human papillomavirus type 16 E6 to immortalize normal human oral keratinocytes.
    Kim RH; Kang MK; Shin KH; Oo ZM; Han T; Baluda MA; Park NH
    Exp Cell Res; 2007 Feb; 313(3):462-72. PubMed ID: 17161394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p53 in complex with DNA is resistant to ubiquitin-dependent proteolysis in the presence of HPV-16 E6.
    Molinari M; Milner J
    Oncogene; 1995 May; 10(9):1849-54. PubMed ID: 7753560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of telomerase by HPVs.
    Katzenellenbogen RA
    Virus Res; 2017 Mar; 231():50-55. PubMed ID: 27863966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel interaction between HPV E6 and BARD1 (BRCA1-associated ring domain 1) and its biologic roles.
    Yim EK; Lee KH; Myeong J; Tong SY; Um SJ; Park JS
    DNA Cell Biol; 2007 Oct; 26(10):753-61. PubMed ID: 17678435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.
    McMurray HR; McCance DJ
    J Virol; 2004 Jun; 78(11):5698-706. PubMed ID: 15140967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Requirement of E7 oncoprotein for viability of HeLa cells.
    Nishimura A; Nakahara T; Ueno T; Sasaki K; Yoshida S; Kyo S; Howley PM; Sakai H
    Microbes Infect; 2006 Apr; 8(4):984-93. PubMed ID: 16500131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.
    Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM
    J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background.
    Massimi P; Shai A; Lambert P; Banks L
    Oncogene; 2008 Mar; 27(12):1800-4. PubMed ID: 17934525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression.
    McMurray HR; McCance DJ
    J Virol; 2003 Sep; 77(18):9852-61. PubMed ID: 12941894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between hTERT activation by HPV E6 proteins and oncogenic risk.
    Van Doorslaer K; Burk RD
    Virology; 2012 Nov; 433(1):216-9. PubMed ID: 22925336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase.
    Kelley ML; Keiger KE; Lee CJ; Huibregtse JM
    J Virol; 2005 Mar; 79(6):3737-47. PubMed ID: 15731267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishment of immortalized human hepatocytes by introduction of HPV16 E6/E7 and hTERT as cell sources for liver cell-based therapy.
    Tsuruga Y; Kiyono T; Matsushita M; Takahashi T; Kasai H; Matsumoto S; Todo S
    Cell Transplant; 2008; 17(9):1083-94. PubMed ID: 19177844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The roles of E6-AP and MDM2 in p53 regulation in human papillomavirus-positive cervical cancer cells.
    Traidej M; Chen L; Yu D; Agrawal S; Chen J
    Antisense Nucleic Acid Drug Dev; 2000 Feb; 10(1):17-27. PubMed ID: 10726657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.
    Zhuang ZH; Tsao SW; Deng W; Wang JD; Xia HH; He H; Feng HC; Wang LD; Gu Q; Lam SK; Lin MC; Kung HF; Wong BC
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1613-20. PubMed ID: 18717758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defining the minimal requirements for papilloma viral E6-mediated inhibition of human p53 activity in fission yeast.
    Waddell S; Jenkins JR
    Oncogene; 1998 Apr; 16(13):1759-65. PubMed ID: 9582024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the interactions of human papillomavirus type 16 E6 with p53 and E6-associated protein in insect and human cells.
    Daniels PR; Sanders CM; Maitland NJ
    J Gen Virol; 1998 Mar; 79 ( Pt 3)():489-99. PubMed ID: 9519827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6.
    Duffy CL; Phillips SL; Klingelhutz AJ
    Virology; 2003 Sep; 314(1):196-205. PubMed ID: 14517073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.